Self-reported financial hardship was significantly associated with insomnia risk, poor sleep quality, and short sleep ...

Latent tuberculosis infection-positivity is common among patients with systemic vasculitis and is associated with BD and smoking history.

The FDA has approved Purified Cortrophin Gel (repository corticotropin injection USP) in a prefilled syringe presentation.

Globally, increases in obesity are projected to continue to 2050 for children and adolescents, and the prevalence of overweight and obesity is set to increase among adults.

Osteoarthritis was not associated with cognitive decline, though patients with OA and comorbid depression faced a greater risk for cognitive impairment.

Although overall cancer mortality rates are declining for Black patients, they continue to have higher mortality rates than White patients for some cancers.

There appears to be a connection between prenatal per- and polyfluoroalkyl substance (PFAS) serum concentrations and some childhood cancers.

The burden of osteoarthritis (OA) is increasing among postmenopausal women, according to a study published online.

The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for obinutuzumab (Gazyva®) for the treatment of lupus nephritis.

The FDA has approved Stoboclo (denosumab-bmwo), a biosimilar to Prolia (denosumab), and Osenvelt (denosumab-bmwo), a biosimilar to Xgeva (denosumab).

For patients with inflammatory bowel disease (IBD), risk factors associated with Clostridioides difficile infection (CDI) include recent diagnosis, corticosteroid usage, and hospitalization.

Sexual satisfaction is negatively impacted by living with Sjögren disease and is strongly correlated with depressive symptoms.